Quantifying time toxicity in lung cancer trials with Time Toxicity Units

Streamlining clinical trial protocols by measuring time toxicityПодробнее

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 TrialПодробнее

How can time toxicity be reduced for patients in lung cancer clinical trials?Подробнее

Role of the Pulmonologist in the Early Detection & Management of Lung Cancer Treatment ComplicationsПодробнее

Financial Toxicity of Cancer Treatment: An OverviewПодробнее

Webinar: How do you quantify the benefit of research in the absence of?Подробнее

Disease Pathway Management in Lung Cancer Care: Reducing Wait Time for Diagnosis and TreatmentПодробнее

New roles of lung CT in ILD and lung cancer - quantifying and predicting diseaseПодробнее

I was Diagnosed with Stage 4 Lung Cancer!Подробнее

Dr Jacob Scott: Quantifying the biological effect of radiation with genomics: personalise RT dosingПодробнее

What Changes Monday Morning? | Post ASCO21 Lung Cancer PanelПодробнее

Quantifying and monitoring overdiagnosis in cancer screeningПодробнее

Managing hematological and GI toxicities in patients with lung cancerПодробнее

Quantifying human exposure to chemicals in consumer products: High-Throughput methods for life cycleПодробнее

Immunotherapy Toxicity Management in NSCLCПодробнее

A Simple, One-Time, Inexpensive and Non-Toxic Intervention to Improve Cancer SurvivalПодробнее

Liquid biopsy in lung cancer: state of the art and future applications- A.MarchettiПодробнее

QCRI Gairdner: Pitfalls Promise Cancer TrialsПодробнее

2021-10 Beyond Chemo: Toxicity of Anticancer Immune Checkpoint Inhibitors (Andrew Stolbach)Подробнее